Member Info for marik

Looking very rosy. I'm still thinking that this is Jogmec with one of the major auto players making a bid for the EUA assets.

The more varied the uses for affimers the better. I'm liking the depth of collaborations by the Avacta team.

The term BUYER is legal speak for the acquiring company used in the terms document that EUA will or have received.

I have to agree JORC is next. But what an update! It clearly states that all systems are go. Any MM who hasn't done their homework has had it done for them. What a fantastic BoD, I've not seen this kind of commitment and determination from a company.

p.p.s. the paperwork will be sent in the post.

p.s. for anyone else who doesn't contribute themselves even after 2000 posts, or if you have a weak grasp of the basics and want something to do, feel free to join Vegas22 in counting my posts. Thanking you in advance.

Appreciate your effort for looking and counting, very touching. Your poetry is something I aspire to - simple, effective and a valuable contribution to the board. With more than 2000 identical examples to chose from, it was a difficult choice:

"Will the real Sujood please stand up... Please stand up"

Thank you

Covid variants mutate and can make the vaccine less effective.

https://www.news-medical.net/amp/news/20211022/Mu-and-C12-variant-spike-proteins-partially-resistant-to-neutralization-by-vaccine-elicited-antibodies.aspx

Actually Rorkes don't respond... be the bigger man.

Ophidian obviously caught you out, there is no harm in just holding your hand up.

Rorkes don't let it get to you. Strike a pause.

You are so much more than a philosopher. Polite and even providing advice, almost like a social worker. But I know that you are not a social worker, you are so much more.

I know Ophidian got you there with the cinders remark, but don't let that get to you.

BTW what do you think of the post pinned on egberts twitter?

People should still wear masks and take the vaccine.

Restating my previous point. Looking at the figures, therapeutic sales in oncology are likely to be around $250B by 2024, (12% CAGR). With an expansion to the market due to "longer treatment cycles and wider patient eligibility", I would certainly agree to the market being closer to the $300B+ mark. Also interesting are the recent oncology acquisitions are in the billions; Array BioPharma ($11B), Five Prime ($1.9B), Grail ($8B), NBE (1.4B) and Immunomedics($21). Partnerships are also rife with Daiichi Sankyo and IDEAYA as good examples with a $3B collaboration for Genmab.

Positive pK data and this could be huge. My view would be £25 per share from here. With the AVA6000 trial going well, the HUA already applied for and APAC ready to go soon, we will certainly have a positive future ahead.

Wonga you speak like a true Olympian.

@Rorkes I did not guess you were a philosophical kind of guy. I've been busy today doing some paperwork for a little project I am doing, but rest assured I'll focus more here when that is done.

What did you think of my Rorkes-NDN link? Did you really like it or were you just being polite?

I noticed an ever so small level of annoyance with the "squarky seagul" comment, try not to let it get to you. I did not think there would be many seaguls from your neck of the woods?

Yes, that's what I'm thinking.

"Do they make any unsubstantiated claims?"

You know how ndn is always on point and fully substantial.

Rorkes i like it when they write long essays it helps me glaze over and I find it very soothing. But also the sp usually goes up.

You are welcome